EMA is­sues warn­ing of IVF drug short­age due to man­u­fac­tur­ing is­sues

The Eu­ro­pean Med­i­cines Agency re­cent­ly not­ed the short­age of a drug that is used fre­quent­ly in IVF pro­ce­dures where women have ovar­i­an stim­u­la­tion (i.e. fer­til­i­ty treat­ment where the ovaries are stim­u­lat­ed to pro­duce more eggs).

The drug, known as cetrotide, is now fac­ing a short­age in Eu­rope due to a po­ten­tial man­u­fac­tur­ing is­sue.

The EMA’s warn­ing on Wednes­day states that a tech­ni­cal is­sue at the main man­u­fac­tur­ing site for cetrotide re­sult­ed in the clo­sure of the site be­tween De­cem­ber 2021 and March of this year. This led to re­duc­tions and de­lays in the sup­ply of cetrotide.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER